Clinical Medicine · 2016 · 119 citations · 22 references
MedicineEndocrinologyGynecologyEndocrine GeneticsMetabolic RegulationReproductive EndocrinologyInsulin ResistanceOvarian FunctionOvarian PhysiologyPolycystic Ovary SyndromeWeight LossWeight ManagementBody Weight-related Ovulatory DysfunctionFollicular Development DisordersImpaired Insulin SensitivityInsulin Sensitivity AdaptationObesity-related HypogonadismPolycystic Ovary Syndrome ComorbidityPolycystic Ovary Syndrome TreatmentPolycystic Ovary Syndrome-associated Insulin Resistance
<h3>Abstract</h3> Polycystic ovary syndrome (PCOS) is a common condition that typically develops in reproductive-age women. The cardinal clinical and biochemical characteristics of PCOS include reproductive dysfunction and hyperandrogenic features. PCOS is also strongly associated with obesity based on data from epidemiological and genetic studies. Accordingly, PCOS often becomes manifest in those women who carry a genetic predisposition to its development, and who also gain weight. The role of weight gain and obesity in the development of PCOS is mediated at least in part, through worsening of insulin resistance. Compensatory hyperinsulinaemia that develops in this context disrupts ovarian function, with enhanced androgen production and arrest of ovarian follicular development. Insulin resistance also contributes to the strong association of PCOS with adverse metabolic risk, including dysglycaemia, dyslipidaemia and fatty liver. Conversely, modest weight loss of just 5% body weight with improvement in insulin sensitivity, frequently results in clinically meaningful improvements in hyperandrogenic, reproductive and metabolic features. Future developments of novel therapies for obese women with PCOS should focus on promotion of weight loss and improvement in insulin sensitivity. In this context, therapies that complement lifestyle changes such as dietary modification and exercise, particularly during the maintenance phase of weight loss are important. Putative novel targets for therapy in PCOS include human brown adipose tissue.
22
Identification and Importance of Brown Adipose Tissue in Adult Humans
Aaron M. Cypess, Sanaz Lehman, Gethin Williams et al. · New England Journal of Medicine · 2009 · 4.4K citations · Full text
Functional Brown Adipose Tissue in Healthy Adults
Kirsi A. Virtanen, Martin E. Lidell, Janne Orava et al. · New England Journal of Medicine · 2009 · 3K citations · Full text